Exploring the Potential and Challenges of CRISPR Delivery and Therapeutics for Genetic Disease Treatment
Open Access
- 27 May 2024
- journal article
- review article
- Published by Wiley in Advanced Functional Materials
- Vol. 34 (38)
Abstract
Human genetic disorders, arising from a range of genetic irregularities, can significantly affect human physiology, often with limited available treatment options. The development of the CRISPR system, facilitating precise editing of the genome, has opened new avenues for addressing a range of mutations found in various genetic disorders. However, there is currently a lack of comprehensive reviews that specifically address the application of CRISPR in genetic diseases. To bridge this gap, this review focuses on exploring the advancements in CRISPR technology and their utility in therapeutic approaches for various genetic disorders. This review introduces human genetic disorders, explains the fundamental mechanisms of CRISPR editing, and highlights the latest advancements in CRISPR technology. Additionally, it examines three CRISPR delivery techniques, including physical delivery, viral vectors, and nanocarriers. It further reviews CRISPR's applications in therapeutic approaches for genetic disorders. Finally, it identifies the primary hurdles associated with industrial development and ethics considerations that should be addressed before the application of CRISPR in a medical context.Keywords
This publication has 232 references indexed in Scilit:
- CRISPR delivery with extracellular vesicles: Promises and challengesJournal of Extracellular Biology, 2023
- Outcomes of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia Treated With β-BlockersJAMA Cardiology, 2022
- CRISPR-Cas9-Mediated Gene Therapy in Neurological DisordersMolecular Neurobiology, 2021
- Engineered extracellular vesicles as versatile ribonucleoprotein delivery vehicles for efficient and safe CRISPR genome editingJournal of Extracellular Vesicles, 2021
- Cationic Polymer‐Mediated CRISPR/Cas9 Plasmid Delivery for Genome EditingMacromolecular Rapid Communications, 2018
- Exosome–Liposome Hybrid Nanoparticles Deliver CRISPR/Cas9 System in MSCsAdvanced Science, 2018
- Non‐Viral CRISPR/Cas Gene Editing In Vitro and In Vivo Enabled by Synthetic Nanoparticle Co‐Delivery of Cas9 mRNA and sgRNAAngewandte Chemie, 2016
- Polymer–Lipid Nanoparticles for Systemic Delivery of mRNA to the LungsAngewandte Chemie, 2016
- Self‐Assembled DNA Nanoclews for the Efficient Delivery of CRISPR–Cas9 for Genome EditingAngewandte Chemie, 2015
- Clinical practiceEuropean Journal of Pediatrics, 2009